Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force

Published on Feb 1, 2017in European Urology17.947
· DOI :10.1016/J.EURURO.2016.09.041
Silvia Villa6
Estimated H-index: 6
,
Friederike Kendel16
Estimated H-index: 16
+ 16 AuthorsLara Bellardita10
Estimated H-index: 10
Sources
Abstract
Abstract Background Literature on the health-related quality of life (HRQoL) for men with localized prostate cancer (PCa) on active surveillance (AS) shows a need for methodological guidance regarding HRQoL issues and how to address them. Objective The European School of Oncology Task Force (ESO TF) aimed to identify a core set of research questions and related measures to include in AS HRQoL studies. Design, setting, and participants A modified Delphi study was used to reach consensus on AS HRQoL research topics and tools between 2014 and 2015. Data were collected by engaging a multidisciplinary team of 15 experts. Outcome measurements and statistical analysis An open-ended questionnaire was used to collect information from ESO TF members regarding issues in AS HRQoL research. Then a structured questionnaire was used to collect ratings on the usefulness/importance of different AS HRQoL aspects. Items that ≥80% of ESO TF members rated as useful/important were retained. Items with a 50–80% rating were discussed to reach final agreement. Results and limitations Six main research questions concerning the selection of outcome measures, measurement tools, and comparison groups were identified as relevant. The core set of measures identified were related to individual characteristics, psychological dimensions; decision-making–related issues, and physical functioning. The multidisciplinary expertise of ESO TF members was a significant asset, even if bringing different backgrounds to the discussion table represented a challenge. Conclusions HRQoL measures have to be sensitive to the specific needs of men on AS. The definition of HRQoL outcomes will enhance a broader understanding of the HRQoL of men on AS and sustain patient-centered medicine. Patient summary An international panel agreed on a set of health-related quality-of-life aspects to be assessed among men on active surveillance for prostate cancer. Valid relevant questionnaires were identified. The experts' indications lay a foundation for future research and clinical practice.
Figures & Tables
Download
📖 Papers frequently viewed together
1 Citations
1 Citations
11 Citations
References31
Newest
#1Andrew J Simpkin (UoB: University of Bristol)H-Index: 19
#2Kate Tilling (UoB: University of Bristol)H-Index: 83
Last. Jenny L Donovan (UoB: University of Bristol)H-Index: 106
view all 9 authors...
Abstract Context Many men with clinically localized prostate cancer are being monitored as part of active surveillance (AS) programs, but little is known about reasons for receiving radical treatment. Objectives A systematic review of the evidence about AS was undertaken, with a meta-analysis to identify predictors of radical treatment. Evidence acquisition A comprehensive search of the Embase, MEDLINE and Web of Knowledge databases to March 2014 was performed. Studies reporting on men with loca...
78 CitationsSource
#1Lara BellarditaH-Index: 10
#2Riccardo ValdagniH-Index: 51
Last. Ida J. Korfage (Erasmus University Medical Center)H-Index: 36
view all 8 authors...
Abstract Context The optimal management of screen-detected, localised prostate cancer remains controversial, related to overtreatment issues of screening and the nonrandomised evidence base. Active surveillance (AS) aims to delay or avoid curative therapy but may potentially harm patients' well-being through living with untreated prostate cancer. Objective To systematically review the literature on quality of life (QoL) in patients undergoing AS. Evidence acquisition Embase, Medline, Psychinfo, ...
87 CitationsSource
#1Lionne D. F. Venderbos (EUR: Erasmus University Rotterdam)H-Index: 10
#2Roderick C.N. van den Bergh (EUR: Erasmus University Rotterdam)H-Index: 37
Last. Ida J. Korfage (EUR: Erasmus University Rotterdam)H-Index: 36
view all 8 authors...
textabstractObjective: Patients with potentially indolent prostate cancer (PC) can be managed with active surveillance (AS). Our objective was to analyse how anxiety and distress develop in men with untreated PC and whether highly anxious men quit AS. Methods: One hundred and fifty Dutch patients who opted for AS in the Prostate cancer Research International: Active Surveillance Study were invited to participate in an additional prospective, longitudinal quality of life (QoL) study within 6month...
51 CitationsSource
#1Gregory Carter (University of Newcastle)H-Index: 34
#2Kerrie Clover (University of Newcastle)H-Index: 22
Last. Sylvie D. Lambert (McGill University)H-Index: 25
view all 8 authors...
Abstract Background Active Surveillance (AS) is recommended for the treatment of localised prostate cancer; however this option may be under-used, at least in part because of expectations of psychological adverse events in those offered or accepting AS. Objective (1) Determine the impact on psychological wellbeing when treated with AS (non-comparative studies). (2) Compare AS with active treatments for the impact on psychological wellbeing (comparative studies). Method We used the PRISMA guideli...
35 CitationsSource
#1J Anderson (Deakin University)H-Index: 2
#2Susan Burney (Monash University)H-Index: 21
Last. Mark Frydenberg (Monash University)H-Index: 47
view all 7 authors...
Objectives To describe a range of anxieties in men on active surveillance (AS) for prostate cancer and determine which of these anxieties predicted health-related quality of life (HRQL). Patients and Methods In all, 260 men with prostate cancer on AS were invited to complete psychological measures including the Hospital and Anxiety Depression Scale; the State-Trait Anxiety Inventory-Trait Scale; the Memorial Anxiety Scale for Prostate Cancer; and the Functional Assessment of Cancer Therapy Scale...
45 CitationsSource
#1Lara BellarditaH-Index: 10
#2Silvia VillaH-Index: 6
Last. Riccardo ValdagniH-Index: 51
view all 3 authors...
Purpose of reviewTo summarize the literature on the predictors of quality of life (QoL) of patients with prostate cancer (PCa) on active surveillance and to highlight both risk factors of poor QoL and resilience factors that facilitate decision-making and promote adherence to active surveillance.Rec
7 CitationsSource
#1Axel Heidenreich (RWTH Aachen University)H-Index: 72
#2Patrick J. BastianH-Index: 51
Last. Nicolas MottetH-Index: 40
view all 11 authors...
Abstract Context The most recent summary of the European Association of Urology (EAU) guidelines on prostate cancer (PCa) was published in 2011. Objective To present a summary of the 2013 version of the EAU guidelines on screening, diagnosis, and local treatment with curative intent of clinically organ-confined PCa. Evidence acquisition A literature review of the new data emerging from 2011 to 2013 has been performed by the EAU PCa guideline group. The guidelines have been updated, and levels of...
1,404 CitationsSource
#1Sanoj Punnen (UCSF: University of California, San Francisco)H-Index: 10
#1Sanoj Punnen (UCSF: University of California, San Francisco)H-Index: 16
Last. Matthew R. Cooperberg (UCSF: University of California, San Francisco)H-Index: 74
view all 6 authors...
Objective To evaluate the prevalence of depression, anxiety and distress among active surveillance (AS) and radical prostatectomy (RP) patients. To evaluate the impact of these symptoms at baseline on urinary and sexual quality of life at follow-up. Patients and Methods Patients managed with AS or RP who completed validated questionnaires assessing levels of depression, anxiety, distress and urinary (UF) and sexual function (SF) and bother comprised the final analytic cohort. These measures were...
70 CitationsSource
#1Heidi A. van Vugt (EUR: Erasmus University Rotterdam)H-Index: 8
#2Monique J. RoobolH-Index: 76
Last. Ewout W. Steyerberg (EUR: Erasmus University Rotterdam)H-Index: 157
view all 11 authors...
Study Type – Prognosis (cohort series) Level of Evidence 2a What's known on the subject? and What does the study add? The present study is one of the first to investigate urologists' and patients' compliance with recommendations based on a risk calculator that calculates the probability of indolent prostate cancer. A threshold was set for a recommendation of active surveillance vs active treatment. Active surveillance recommendations based on a prostate cancer risk calculator were followed by mo...
18 CitationsSource
#1Louis DenisH-Index: 21
#2Monique J. Roobol (EUR: Erasmus University Rotterdam)H-Index: 76
view all 3 authors...
AbstractThe democratization of civil society and the development of modern medicine changed the sacrosanct doctor-patient relationship to a doctor-partner dialogue. Values and respect were lost in the process where common courtesy and empathy in trust were replaced by patient rights. Launch of Europa Uomo. Europa Uomo, the European prostate cancer coalition, represents 22 national, autonomous patient support groups. Its aim includes increasing the awareness of prostate diseases, support individu...
17 CitationsSource
Cited By8
Newest
#1Paola DordoniH-Index: 6
#1Paola DordoniH-Index: 2
Last. Lara BellarditaH-Index: 10
view all 11 authors...
OBJECTIVE: To investigate whether prostate cancer (PCa) patients' coping strategies (i.e., fighting spirit, anxious preoccupation, fatalism, helplessness/hopelessness, and avoidance) significantly change during the first 3-year follow-up period of active surveillance (AS). MATERIALS AND METHODS: Altogether, 104 patients on AS completed the Mini-Mental Adjustment to Cancer (Mini-MAC) at baseline (T0), at 10 and 12 months after diagnostic biopsy (T1 and T2, respectively) and then at 24- (T3) and 3...
2 CitationsSource
Background The psychological burden possibly deriving from not immediately undergoing radical treatment for prostate cancer (PCa) could be a potential disadvantage of active surveillance (AS), especially in the eve of some relevant clinical exams [i.e., re-biopsy, prostate-specific antigen (PSA) test, and medical examination]. Even if it is known from the literature that the majority of PCa men in AS do not report heightened anxiety, there is a minority of patients who show clinically significan...
Source
#1Julia Menichetti (University of Oslo)H-Index: 9
#2Letizia De LucaH-Index: 2
Last. Lara BellarditaH-Index: 10
view all 7 authors...
OBJECTIVE: Health promotion is a key aspect for health outcomes of prostate cancer (PCa) patients. However, it has been poorly explored among patients following monitoring programmes, for example Active Surveillance (AS). This study aimed to explore PCa patients' perceptions of health promotion during AS. METHODS: An explorative qualitative research design was adopted. Four focus groups were used to collected data from 24 men enrolled in the Prostate Cancer Research International: AS (PRIAS) pro...
1 CitationsSource
#2Claudia RepettoH-Index: 17
Last. Lara BellarditaH-Index: 10
view all 12 authors...
Purpose:The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) is a self-report questionnaire that was developed in English to assess prostate cancer (PCa)-related anxiety. The aim of this study w...
3 CitationsSource
Several studies have been conducted on the quality of life (QoL) in men with low risk prostate cancer (PCa) who choose active surveillance (AS). While recent reviews have shown a lack of consistency among the available QoL-studies, a few key points have been identi ed, including decision-making (DM)- related issues and their potential effect on QoL. The importance of this theme has also been recently highlighted by the international task force of the European School of Oncology. However, to our ...
6 CitationsSource
#1Fabio CampodonicoH-Index: 13
Last. C. IntroiniH-Index: 2
view all 6 authors...
Source
#1Lauren M. HurwitzH-Index: 9
#2Jennifer CullenH-Index: 15
Last. Jennifer CullenH-Index: 26
view all 2 authors...
Source
#1M.B. Busstra (Erasmus University Medical Center)H-Index: 2
#1Martijn B. Busstra (Erasmus University Medical Center)H-Index: 10
Last. Monique J. RoobolH-Index: 76
view all 2 authors...
Source